Globe Life (GL)

• Market cap: $10.3B
• 1 day: -0.51%
• 5 days: 1.16%
• 1 month: -6.36%
• 3 months: 0.85%
• 6 months: 15.27%
• Year to date: 9.89%
• 1 year: 61.93%
• 5 years: 49.79%
• 10 years: 119.82%
• Sector: Financials
• Industry: Life Insurance

About: Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Employees: 3,732

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

104% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 47

9% more capital invested

Capital invested by funds: $7.15B [Q3] → $7.78B (+$629M) [Q4]

8% more funds holding

Funds holding: 519 [Q3] → 561 (+42) [Q4]

7.55% more ownership

Funds ownership: 75.52% [Q3] → 83.08% (+7.55%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]

16% less call options, than puts

Call options by funds: $91.3M | Put options by funds: $108M

16% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 200

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $117 5% downside
• Avg. target: $140 13% upside
• High target: $152 23% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Wells Fargo Elyse Greenspan 54% 1-year accuracy 61 / 113 met price target	14% upside $140	Overweight Maintained	10 Apr 2025
Morgan Stanley Nigel Dally 64% 1-year accuracy 7 / 11 met price target	5% downside $117	Equal-Weight Maintained	10 Apr 2025
Piper Sandler John Barnidge 47% 1-year accuracy 22 / 47 met price target	23% upside $152	Overweight Maintained	2 Apr 2025
JP Morgan Jimmy Bhullar 56% 1-year accuracy 20 / 36 met price target	18% upside $145	Overweight Maintained	2 Apr 2025
Keefe, Bruyette & Woods Ryan Krueger 62% 1-year accuracy 13 / 21 met price target	18% upside $145	Outperform Maintained	12 Feb 2025